Discovered and developed in Australia by CSL scientists, ANDEMBRY is CSL’s first monoclonal antibody treatment; reinforces company’s commitment to providing a wide range of treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback